PuSH - Publikationsserver des Helmholtz Zentrums München

Becker, M.* ; Strengert, M.* ; Junker, D.* ; Kaiser, P.D.* ; Kerrinnes, T.* ; Traenkle, B.* ; Dinter, H.* ; Häring, J.* ; Ghozzi, S.* ; Zeck, A.* ; Weise, F.* ; Peter, A. ; Hörber, S. ; Fink, S.* ; Ruoff, F.* ; Dulovic, A.* ; Bakchoul, T.* ; Baillot, A.* ; Lohse, S.* ; Cornberg, M.* ; Illig, T.* ; Gottlieb, J.* ; Smola, S.* ; Karch, A.* ; Berger, K.* ; Rammensee, H.G.* ; Schenke-Layland, K.* ; Nelde, A.* ; Märklin, M.* ; Heitmann, J.S.* ; Walz, J.S.* ; Templin, M.* ; Joos, T.O.* ; Rothbauer, U.* ; Krause, G.* ; Schneiderhan-Marra, N.*

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.

Nat. Commun. 12:1152 (2021)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed analysis is required to understand the manifestation and progression of COVID-19, monitor seroconversion within the general population, and support vaccine development. The majority of currently available commercial serological assays only quantify the SARS-CoV-2 antibody response against individual antigens, limiting our understanding of the immune response. To overcome this, we have developed a multiplex immunoassay (MultiCoV-Ab) including spike and nucleocapsid proteins of SARS-CoV-2 and the endemic human coronaviruses. Compared to three broadly used commercial in vitro diagnostic tests, our MultiCoV-Ab achieves a higher sensitivity and specificity when analyzing a well-characterized sample set of SARS-CoV-2 infected and uninfected individuals. We find a high response against endemic coronaviruses in our sample set, but no consistent cross-reactive IgG response patterns against SARS-CoV-2. Here we show a robust, high-content-enabled, antigen-saving multiplex assay suited to both monitoring vaccination studies and facilitating epidemiologic screenings for humoral immunity towards pandemic and endemic coronaviruses.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 12, Heft: 1, Seiten: , Artikelnummer: 1152 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)
Förderungen European Union
Initiative and Networking Fund of the Helmholtz Association of German Research Centres